Literature DB >> 28577248

Pathological Findings of the Antral and Pyloric Smooth Muscle in Patients with Gastroparesis-Like Syndrome Compared to Gastroparesis: Similarities and Differences.

Mohammad Bashashati1, Sharareh Moraveji2, Alireza Torabi3, Irene Sarosiek2, Brian R Davis4, Jesus Diaz5, Richard W McCallum6.   

Abstract

BACKGROUND: Gastroparesis (GP)-like syndrome presents with the symptoms of GP but without delayed gastric emptying (GE). Whether GP-like syndrome is part of a spectrum of GP is not clear. This study aimed to compare the histopathological features of antral and pyloric smooth muscle tissue in GP and GP-like syndrome.
METHODS: Full-thickness antral and/or pyloric biopsies were obtained from 37 GP and 18 GP-like syndrome patients who underwent abdominal surgery to place a gastric electrical stimulator or jejunal feeding tube and/or pyloroplasty. The tissues were stained with H&amp;E, C-Kit, and trichrome. Based on previous control data, an interstitial cells of Cajal (ICC) count of <10 per high power field in the antrum and/or pylorus was considered depletion. Baseline total symptom score (TSS) was recorded.
RESULTS: Twenty-four GP and 7 GP-like patients had pyloric biopsies. Pyloric ICC loss was observed in 20/24 (83.3%) GP and 2/7 (28.6%) GP-like patients (p < 0.01). Fibrosis was detected in the pyloric tissue of 20/24 (83.3%) GP and 2/7 (28.6%) GP-like patients who had pyloric trichrome staining (p < 0.01). Seventeen out of 24 (70.8%) GP patients with pyloric biopsies had concomitant pyloric ICC loss and fibrosis, while only one GP-like patient had ICC loss and simultaneous pyloric fibrosis. GP patients had a greater TSS compared to GP-like patients. In GP patients, those with pyloric ICC loss had a greater TSS compared to those with normal ICC. GP patients with pyloric fibrosis had a higher TSS compared to those without pyloric fibrosis.
CONCLUSIONS: Compared to GP-like patients, the pyloric histopathological findings of ICC loss and fibrosis are common in GP and predict a greater symptom score. These pathological findings might be considered as markers of "pyloric dysfunction" and explain delayed GE in GP.

Entities:  

Keywords:  Fibrosis; Gastroparesis; Interstitial cells of Cajal; Pathology; Pylorus

Mesh:

Year:  2017        PMID: 28577248     DOI: 10.1007/s10620-017-4629-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.

Authors:  Thomas L Abell; Michael Camilleri; Kevin Donohoe; William L Hasler; Henry C Lin; Alan H Maurer; Richard W McCallum; Thomas Nowak; Martin L Nusynowitz; Henry P Parkman; Paul Shreve; Lawrence A Szarka; William J Snape; Harvey A Ziessman
Journal:  Am J Gastroenterol       Date:  2007-11-19       Impact factor: 10.864

2.  Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying.

Authors:  Pankaj J Pasricha; Ryan Colvin; Katherine Yates; William L Hasler; Thomas L Abell; Aynur Unalp-Arida; Linda Nguyen; Gianrico Farrugia; Kenneth L Koch; Henry P Parkman; William J Snape; Linda Lee; James Tonascia; Frank Hamilton
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

3.  The addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesis.

Authors:  I Sarosiek; J Forster; Z Lin; S Cherry; J Sarosiek; R McCallum
Journal:  Neurogastroenterol Motil       Date:  2012-10-31       Impact factor: 3.598

4.  Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies.

Authors:  Justin Harberson; Rebecca M Thomas; Sean P Harbison; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

5.  Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients With Chronic Unexplained Nausea and Vomiting.

Authors:  Timothy R Angeli; Leo K Cheng; Peng Du; Tim Hsu-Han Wang; Cheryl E Bernard; Maria-Giuliana Vannucchi; Maria Simonetta Faussone-Pellegrini; Christopher Lahr; Ryash Vather; John A Windsor; Gianrico Farrugia; Thomas L Abell; Gregory O'Grady
Journal:  Gastroenterology       Date:  2015-04-08       Impact factor: 22.682

6.  Assessment of gastric emptying using a low fat meal: establishment of international control values.

Authors:  G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

7.  Cellular changes in diabetic and idiopathic gastroparesis.

Authors:  Madhusudan Grover; Gianrico Farrugia; Matthew S Lurken; Cheryl E Bernard; Maria Simonetta Faussone-Pellegrini; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Ünalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Pankaj J Pasricha
Journal:  Gastroenterology       Date:  2011-02-04       Impact factor: 22.682

8.  Pyloric dysfunction in diabetics with recurrent nausea and vomiting.

Authors:  F Mearin; M Camilleri; J R Malagelada
Journal:  Gastroenterology       Date:  1986-06       Impact factor: 22.682

9.  Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation.

Authors:  Z Lin; Q Hou; I Sarosiek; J Forster; R W McCallum
Journal:  Neurogastroenterol Motil       Date:  2007-12-11       Impact factor: 3.598

10.  Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.

Authors:  Andrea Shin; Michael Camilleri; Irene Busciglio; Duane Burton; Elizabeth Stoner; Patrick Noonan; Keith Gottesdiener; Steven A Smith; Adrian Vella; Alan R Zinsmeister
Journal:  Diabetes Care       Date:  2012-09-06       Impact factor: 19.112

View more
  8 in total

1.  Understanding the Differences Between Gastroparesis and Gastroparesis-Like Syndrome: Filling a GaPing Hole?

Authors:  Jonathan Gotfried; Ron Schey
Journal:  Dig Dis Sci       Date:  2017-10       Impact factor: 3.199

Review 2.  Gastroparesis: a turning point in understanding and treatment.

Authors:  Madhusudan Grover; Gianrico Farrugia; Vincenzo Stanghellini
Journal:  Gut       Date:  2019-09-28       Impact factor: 23.059

3.  A Critical Review of the Current Clinical Landscape of Gastroparesis.

Authors:  Chimi L Fosso; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 4.  Gastroparesis.

Authors:  Michael Camilleri; Kenton M Sanders
Journal:  Gastroenterology       Date:  2021-10-27       Impact factor: 22.682

Review 5.  Strategies to Refine Gastric Stimulation and Pacing Protocols: Experimental and Modeling Approaches.

Authors:  Leo K Cheng; Nipuni D Nagahawatte; Recep Avci; Peng Du; Zhongming Liu; Niranchan Paskaranandavadivel
Journal:  Front Neurosci       Date:  2021-04-22       Impact factor: 5.152

Review 6.  Gastric Electrical Stimulation for Treatment of Refractory Gastroparesis: the Current Approach to Management.

Authors:  Aaron Shanker; Mohammad Bashashati; Ali Rezaie
Journal:  Curr Gastroenterol Rep       Date:  2021-01-22

7.  Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule.

Authors:  Mattis Bekkelund; Dag A Sangnes; Eirik Søfteland; Lars Aabakken; Martin Biermann; Elisabeth K Steinsvik; Trygve Hausken; Georg Dimcevski; Jan Gunnar Hatlebakk
Journal:  Clin Exp Gastroenterol       Date:  2021-04-28

8.  Efficacy of Gastric Electrical Stimulation for Gastroparesis: US/European Comparison.

Authors:  Jordan Burlen; Matt Runnels; Minesh Mehta; Stina Andersson; Philippe Ducrotte; Guillaume Gourcerol; Greger Lindberg; Greg Fullarton; Hasse Abrahamsson; Amar Al-Juburi; Chris Lahr; Hani Rashed; Thomas Abell
Journal:  Gastroenterology Res       Date:  2018-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.